Ordering RecommendationRecommendations when to order or not order the test. May include related or preferred tests.
Use with FNA biopsy of thyroid nodules to diagnose benign or malignant nonmedullary thyroid nodules.
MnemonicUnique test identifier.
THYROG FNA
MethodologyProcess(es) used to perform the test.
Quantitative Chemiluminescent Immunoassay
PerformedDays of the week the test is performed.
Sun-Sat
ReportedExpected turnaround time for a result, beginning when ARUP has received the specimen.
Within 24 hours
New York DOH Approval StatusIndicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Fine needle aspiration in saline.
Specimen Preparation
Centrifuge to remove cellular material. Specimen must be non-viscous and free of particulate matter. Transport 0.5 mL saline needle rinse. (Min: 0.5 mL) Also acceptable: Heparinized specimens.
Storage/Transport Temperature
Frozen.
Unacceptable Conditions
Specimen types other than those listed. Specimens containing EDTA. Viscous specimens.
Reference IntervalNormal range/expected value(s) for a specific disease state. May also include abnormal ranges.
By report
Interpretive DataBackground information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Thyroglobulin (Tg) is measured by the Beckman Coulter Access method. Results obtained with different assay methods or kits cannot be used interchangeably. The Tg result, regardless of concentration, should not be interpreted as absolute evidence for the presence or absence of papillary or follicular thyroid cancer. This test is FDA cleared but is not labeled for use with FNA fluid.
The performance characteristics of this test were determined by ARUP.
Normal values are less than 10 ng/mL (Baloch ZW et al., CytoJournal 2008, 5:1).
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Compliance Category
Laboratory Developed Test (LDT)
NoteAdditional information related to the test.
Hotline History
N/A
CPT CodesThe American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
AliasesOther names that describe the test. Synonyms.